Expanded access: growing importance to public health
J Epidemiol Community Health
.
2018 Jul;72(7):557-558.
doi: 10.1136/jech-2017-210409.
Epub 2018 Apr 7.
Authors
Jan Borysowski
1
2
,
Abha Saxena
3
,
Alison Bateman-House
4
,
Marisa Papaluca
5
,
Joanna Różyńska
6
,
Agata Wnukiewicz-Kozłowska
7
,
Andrzej Górski
1
8
Affiliations
1
Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland.
2
Centre for Research Ethics, Institute of Law Studies, Polish Academy of Sciences, Warsaw, Poland.
3
Coordinator, Global Health Ethics, Department of Information, Evidence and Research, World Health Organization, Geneva, Switzerland.
4
Division of Medical Ethics, NYU Langone Health, NYULH Working Group on Compassionate Use and Pre-Approval Access, New York City, New York, USA.
5
European Medicines Agency, London, UK.
6
Department of Ethics, Institute of Philosophy, University of Warsaw, Warsaw, Poland.
7
Public International and European Law, Faculty of Law, Administration and Economy, Wrocław University, Wrocław, Poland.
8
Laboratory of Bacteriophages, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Warsaw, Poland.
PMID:
29627785
DOI:
10.1136/jech-2017-210409
No abstract available
Keywords:
control of diseases; drug safety; effectiveness; health services; public health.
MeSH terms
Drug Approval
Drugs, Investigational / therapeutic use*
Europe
Health Services Accessibility*
Humans
Public Health*
Substances
Drugs, Investigational
Grants and funding
001/WHO_/World Health Organization/International